Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts

Last Updated: December 7, 2021

Volunteer for clinical trials for CLADRIBINE at ClinicalTrialExchange

DrugPatentWatch Database Preview

CLADRIBINE Drug Patent Profile

Email this page to a colleague

« Back to Dashboard

DrugPatentWatch® Litigation and Generic Entry Outlook for Cladribine

A generic version of CLADRIBINE was approved as cladribine by HIKMA PHARMS on February 28th, 2000.

  Try it Free

Drug patent expirations by year for CLADRIBINE
Drug Prices for CLADRIBINE

See drug prices for CLADRIBINE

Recent Clinical Trials for CLADRIBINE

Identify potential brand extensions & 505(b)(2) entrants

AbbViePhase 1
LanZhou UniversityN/A
Canadian Dermatology FoundationPhase 3

See all CLADRIBINE clinical trials

Pharmacology for CLADRIBINE
Medical Subject Heading (MeSH) Categories for CLADRIBINE

US Patents and Regulatory Information for CLADRIBINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa CLADRIBINE cladribine INJECTABLE;INJECTION 076571-001 Apr 22, 2004 AP RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan Labs Ltd CLADRIBINE cladribine INJECTABLE;INJECTION 200510-001 Oct 6, 2011 AP RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hikma Pharms CLADRIBINE cladribine INJECTABLE;INJECTION 075405-001 Feb 28, 2000 AP RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.